ArticleClinical lung cancer2017

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer.

Matthew S Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.